Publication | Open Access
Effect of Camrelizumab vs Placebo Added to Chemotherapy on Survival and Progression-Free Survival in Patients With Advanced or Metastatic Esophageal Squamous Cell Carcinoma
746
Citations
23
References
2021
Year
ClinicalTrials.gov Identifier: NCT03691090.
| Year | Citations | |
|---|---|---|
Page 1
Page 1